DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Wednesday, 25 May 2016

Shiraz Al-Shahrori



Shiraz Al-Shahrori

Shiraz Al-Shahrori

Regulatory Affairs Manager at Tabuk Pharmaceutical MFG Co

links



Experience


Regulatory Affairs Manager

Tabuk Pharmaceutical MFG Co
 – Present (1 year 9 months)

Business Development Project Manager - New Products MENA

Tabuk Pharmaceutical MFG Co
 –  (1 year 10 months)Amman - Jordan

Regulatory Affairs Quality Management

Tabuk Pharmaceutical MFG Co
 –  (11 months)Jordan - Amman
To assure the RA- MENA of delivering planned KPIs plus continuous improvement in RA- MENA deliverables (results of project management- KPIs and effectiveness).
This role is responsible for the overall success of KPI compliance and improvement for the RA- MENA. And also responsible for the RA- MENA data analysis reports in addition to the successful RA- MENA KPIs External/Internal audits.

RA Senior Team leader - MENA

Tabuk Pharmaceutical MFG Co
 –  (2 years)

RA Team Leader - MENA

Tabuk Pharmaceutical MFG Co
 –  (2 years 9 months)

Compliance Section Head

Hikma Pharmaceuticals
 –  (6 months)

RA Supervisor EU & US

Advanced Pharma
 –  (5 months)

Compliance Officer

JPM
 –  (2 years 8 months)

R&D Analyst

JPM
 –  (3 years 1 month)

Education


JUST

Bachelor of Science (BSc), Applied Chemistry, Very good with first grade





Tabuk Pharmaceutical Manufacturing Company has announced plans to increase its female employee intake in the next 5 years; by hiring 200-300 additional ...
/////

No comments:

Post a Comment